B12 Deficiency & Neuropsychiatric Symptoms
Neuropsychiatric symptoms can occur before obvious anemia. A serum B12 result near the lower end of the reference range may need clinical context and confirmatory markers such as methylmalonic acid.
Last reviewed: May 9, 2026
Short answer
Can this mimic psychiatric symptoms?
- B12 deficiency belongs in the differential when depression, anxiety, cognitive slowing, neuropathy, gait change, macrocytosis, restrictive diet, metformin, acid suppression, or GI disease are part of the same story.
- It does not prove the cause of depression, anxiety, fatigue, brain fog, or attention symptoms by itself.
- Labs need to be read beside timeline, medications, sleep, substances, medical history, and psychiatric presentation.
- The next step may be further testing, specialist referral, psychiatric care, monitoring, or no medical action.
- Do not start supplements, stop medication, or change dose based on this page.
When this belongs in the differential
These patterns do not diagnose the condition. They are reasons to discuss whether it belongs in the clinical review.
- Vegetarian or vegan diet
- Age over 60
- History of gastric surgery or PPI use
- Metformin use
- Peripheral neuropathy
- Glossitis (smooth, red tongue)
- Cognitive decline
The hidden problem: "Normal" still needs context
Standard lab ranges are screening tools, not the whole clinical picture. A value can be flagged as "normal" and still deserve interpretation in context.[1]
Drag the slider to explore different values
Drag the slider to explore different values. The gray zone shows a common reference range; the orange zone shows where this framework would ask more clinical questions.
What standard testing misses
Neuropsychiatric symptoms can occur with "normal" B12 levels. MMA is elevated before serum B12 drops below range.[2]
Diagnostic Coverage
Standard Care
Baseline- Serum B12
- Methylmalonic Acid (MMA) Considered in review
- Homocysteine Considered in review
- Holotranscobalamin Considered in review
Diagnostic Psychiatry
Expanded- Serum B12
- Methylmalonic Acid (MMA) +
- Homocysteine +
- Holotranscobalamin +
Standard care for B12 Deficiency checks 1 test. This framework reviews 4 when the history and presentation support an expanded differential.
Take action
Discuss whether these inputs fit
"I've been experiencing symptoms that could be related to B12 Deficiency. Can we discuss whether targeted testing makes sense?"
Do not use this page to diagnose yourself, start supplements, stop medication, or change a dose. Use it to prepare a better conversation with a licensed clinician.
- Serum B12
- Methylmalonic Acid (MMA)
- Homocysteine
- Holotranscobalamin
Why these inputs may matter
These inputs are included because peer-reviewed research and guidelines keep the question clinically relevant:
- Handb Clin Neurol (2022)
Research shows that low B12 can cause depression, memory problems, and even psychosis - and these symptoms often appear long before blood tests show anemia.
View study → - Clin Med (Lond) (2018)
Clinical review explaining how many medical conditions can cause symptoms that look like mental illness.
View study → - Psychopathology (2024)
Research review showing that low B12 can cause hallucinations, which are reversible with treatment.
View study → - American Academy of Family Physicians (2017)
Screen with serum B12, treat with oral or IM supplementation. The gap: Borderline serum B12 can be difficult to interpret when neuropsychiatric symptoms, macrocytosis, neuropathy, malabsorption risk, or medication exposure are present; MMA can clarify tissue deficiency.
Evidence weight
How strong is the claim?
The condition page separates established medical facts from supported associations and framework-level interpretation. The goal is not to make every symptom medical. The goal is to keep the relevant medical differential visible.
Established
Strong guideline, replicated review, or clear disease mechanism. Still interpreted in context.
Supported
Good evidence and clinical plausibility, but not definitive for every patient or setting.
Proposed
Framework-level reasoning or emerging mechanism. Useful for the differential, not proof.
Speculative
Too early for patient-facing action unless it is clearly labeled and bounded.